CSTL
Castle Biosciences Inc

1,010
Mkt Cap
$995.92M
Volume
483,880.00
52W High
$35.49
52W Low
$14.59
PE Ratio
-74.32
CSTL Fundamentals
Price
$33.45
Prev Close
$34.12
Open
$33.02
50D MA
$25.14
Beta
1.15
Avg. Volume
269,022.70
EPS (Annual)
$0.6236
P/B
2.09
Rev/Employee
$436,358.74
Loading...
Loading...
News
all
press releases
Forget the Fed, Bet on These 4 Stocks With Increasing Cash Flows
Four rising cash-flow stocks, including PRM, TILE, CSTL and GLDD, stand out with upgraded earnings estimates and strong VGM scores.
Zacks·19h ago
News Placeholder
More News
News Placeholder
Zacks.com featured highlights include Castle Biosciences, Perimeter Solutions, South Atlantic Bancshares and Astronics
Castle Biosciences, Perimeter Solutions, South Atlantic Bancshares and Astronics show strong price momentum amid market optimism.
Zacks·3d ago
News Placeholder
Acadian Asset Management LLC Has $11.11 Million Stock Position in Castle Biosciences, Inc. $CSTL
Acadian Asset Management LLC reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL - Free Report) by 19.5% during the 2nd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·3d ago
News Placeholder
Castle Biosciences (NASDAQ:CSTL) Reaches New 52-Week High - Here's Why
Castle Biosciences (NASDAQ:CSTL) Reaches New 52-Week High - Still a Buy...
MarketBeat·3d ago
News Placeholder
4 Stocks With Recent Price Strength to Enhance Your Portfolio
Four stocks, CSTL, PRM, SABK and ATRO show recent gains, signaling potential momentum plays for investors in 2025.
Zacks·4d ago
News Placeholder
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells 6,695 Shares of Stock
Castle Biosciences, Inc. (NASDAQ:CSTL - Get Free Report) insider Derek Maetzold sold 6,695 shares of the stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of...
MarketBeat·7d ago
News Placeholder
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 2,678 Shares
Castle Biosciences, Inc. (NASDAQ:CSTL - Get Free Report) insider Derek Maetzold sold 2,678 shares of the company's stock in a transaction on Wednesday, November 5th. The stock was sold at an average...
MarketBeat·7d ago
News Placeholder
Derek Maetzold Sells 2,678 Shares of Castle Biosciences (NASDAQ:CSTL) Stock
Castle Biosciences, Inc. (NASDAQ:CSTL - Get Free Report) insider Derek Maetzold sold 2,678 shares of Castle Biosciences stock in a transaction dated Wednesday, November 5th. The stock was sold at an...
MarketBeat·8d ago
News Placeholder
Leerink Partnrs Issues Optimistic Forecast for CSTL Earnings
Castle Biosciences, Inc. (NASDAQ:CSTL - Free Report) - Equities researchers at Leerink Partnrs boosted their FY2025 earnings estimates for shares of Castle Biosciences in a research report issued on...
MarketBeat·8d ago
News Placeholder
Recent Price Trend in Castle Biosciences (CSTL) is Your Friend, Here's Why
Castle Biosciences (CSTL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Zacks·10d ago

Latest CSTL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.